Innobic (Asia), the life science arm of national oil and gas conglomerate PTT Plc, plans to spend 1 billion baht in capital expenditure this year to support cancer medicine and plant-based protein factory development projects.
The budget allocation was announced by Buranin Rattanasombat, PTT’s senior executive vice-president and chairman of Innobic (Asia).
The company is cooperating with the Government Pharmaceutical Organization to develop a cancer drug manufacturing facility named GPO Oncology with an investment of 2.5 billion billion baht.
The factory will be located in PTT-owned Wanarom…